Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Abeona Therapeutics (ABEO) Gains from Investment Securities (2016 - 2025)

Historic Gains from Investment Securities for Abeona Therapeutics (ABEO) over the last 14 years, with Q3 2025 value amounting to $394921.0.

  • Abeona Therapeutics' Gains from Investment Securities rose 12294.54% to $394921.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $394921.0, marking a year-over-year increase of 12294.54%. This contributed to the annual value of $584700.0 for FY2024, which is 22664.62% up from last year.
  • Latest data reveals that Abeona Therapeutics reported Gains from Investment Securities of $394921.0 as of Q3 2025, which was up 12294.54% from $5.4 million recorded in Q2 2025.
  • In the past 5 years, Abeona Therapeutics' Gains from Investment Securities ranged from a high of $8.6 million in Q2 2023 and a low of -$24.9 million during Q2 2024
  • Over the past 5 years, Abeona Therapeutics' median Gains from Investment Securities value was $2000.0 (recorded in 2021), while the average stood at -$1.7 million.
  • Data for Abeona Therapeutics' Gains from Investment Securities shows a peak YoY increase of 616500.0% (in 2022) and a maximum YoY decrease of 30510000.0% (in 2022) over the last 5 years.
  • Over the past 5 years, Abeona Therapeutics' Gains from Investment Securities (Quarter) stood at -$16000.0 in 2021, then tumbled by 33575.0% to -$5.4 million in 2022, then skyrocketed by 178.51% to $4.2 million in 2023, then crashed by 260.17% to -$6.8 million in 2024, then skyrocketed by 105.83% to $394921.0 in 2025.
  • Its Gains from Investment Securities was $394921.0 in Q3 2025, compared to $5.4 million in Q2 2025 and -$7.2 million in Q1 2025.